Kairos Ventures

2015

Founded

53

Investments

United States

Offices

Venture Fund

Investor Type

About

Kairos Ventures is a Los Angeles-based venture capital firm founded in 2015 by Jim Demetriades. The firm specializes in early-stage investments in physical and life sciences, focusing on identifying and commercializing transformative discoveries from leading universities and research institutions. Since its inception, Kairos has invested in over 55 companies, collaborating with Nobel Prize and Lasker Award winners, engineers, and entrepreneurs to realize their full scientific and business potential.

Investment Focus

Investment Stage

HQ Locations

Portfolio Companies

Vivodyne, PteroDynamics, Linnea, Actinia, Actuate Therapeutics

Gepgraphic Focus

United States

Key Differentiators

Collaboration with top patent-producing universities and research institutions, Focus on early-stage investments, Hands-on approach to commercialization

Thypical Investment Size

$150,000 to $20 million

Total Funds Raised

$58 million

Visit Website

BioTech

Pre-Seed

Seed

Series A

United States